Annual Drug Patent Expiration for NUBEQA
Nubeqa is a drug marketed by Bayer Healthcare and is included in one NDA. It is available from a single supplier. There are eight patents protecting this drug.
This drug has ninety-six patent family members in thirty-six countries.
The generic ingredient in NUBEQA is darolutamide. One registered supplier for this compound. Additional details are available on the darolutamide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New Patent for the drug Bayer Healthcare NUBEQA